NeuraXion Labs is an AI-first healthcare company building a unified, scalable oncology platform that integrates diagnostics, decision support, and specialist access to transform global healthcare.
NeuraXion Labs — India's AI-First Healthcare Innovation Company
At the heart of our Innovation is TumorXpert — a patented neuro-symbolic AI platform that combines deep learning, symbolic reasoning, and explainable AI to deliver highly accurate, reliable, and transparent cancer detection across multiple tumor types.
TumorXpert (First Mover)
Patented neuro-symbolic AI platform combining deep learning, symbolic reasoning, and explainable AI for cancer detection across multiple tumor types.
Oncology Foundation Model (First Mover)
India's first large foundation model for cancer diagnostics — adaptable for brain, lung, breast, skin, gastrointestinal, and throat cancers.
First Tele Radiologist (First Mover)
Empowers healthcare systems to improve patient outcomes, reduce costs, and scale advanced diagnostics to underserved regions.
Direct to Patients
D2P (First Mover): First specialized D2P platform bringing AI with oncologists, radiologists, pathologists, and patients for multidisciplinary cancer case review.
24/7 Expert Video Consultation (First Mover)
First structured platform providing rapid, 24/7 secured video consultation between oncologists and radiologists at 1/3 cost.
Scalable & Accessible
Cloud-ready, hardware-light deployment for government hospitals, rural health centers, and global facilities with minimal IT investment.
Market Need
Current cancer and tumor diagnosis relies heavily on radiologists manually interpreting MRI/CT/PET scans. This process is slow, prone to human error, and inadequate for early-stage or complex tumor cases. The WHO projects a shortage of 15 million health professionals by 2030. There is no structured platform for multidisciplinary cancer case review in India — each scan currently costs Rs 20–50k with multiple consultancies required. Existing AI solutions offer limited accuracy, poor real-world generalization, and no explainability. Our objective is to cut costs by 1/3 while ensuring equitable access to life-saving cancer diagnostics for every individual worldwide.
Clinical Impact
TumorXpert’s high diagnostic precision enables faster, more targeted interventions, increasing survival rates and reducing long-term neurological impairment in patients.
Operational Efficiency
Automated triaging reduces the workload on specialized radiologists, empowering primary care and district health centers to handle advanced diagnosis, thus mitigating staff shortages and urban-rural disparities.
Economic Value
Early, accurate diagnosis reduces repeat imaging, misdiagnosis costs, and late-stage treatment expenses.
Wider Coverage and Full Cancer Diagnostic Solution:
Foundation model will be leveraged to enable similar diagnosis for all other types of cancers — Skin, Lungs, Breast, Stomach, Throat, and more. India's first multi-organ oncology AI.
Scalability & Accessibility
Secured cloud-ready, hardware-light deployment ensures rapid adoption across government hospitals, rural health centers, and global facilities with minimal IT investment. This allows rapid deployment across healthcare facilities with minimal IT investment, including public hospitals and rural clinics.
A revolutionary approach solving Clinical Diagnosis with Combines power of accuracy (ML) with trust (Symbolic AI), filled Patent for TumorXpert™
The biggest issue in Clinical diagnosis, the sensitivity–specificity trade-off is deeply ingrained in conventional statistical and probabilistic approaches to AI/ML in diagnostic or classification contexts. Typically, tuning a model to increase sensitivity (true positive rate) leads to more false positives (lower specificity), and vice versa. On other hand, Symbolic AI focus on explicit knowledge representation and logical reasoning rather than statistical patterns in data, struggle to handle novel situations and can’t discover hidden pattern.
Hence NeuraXion Labs, developed revolutionary approach TumorXpert™ is a hybrid artificial intelligence approach that combines the strengths of two historically distinct AI paradigms: neural networks and symbolic AI. Combine deep learning (pattern recognition) with symbolic reasoning (logic/knowledge graphs). Symbolic constraints can rule out biologically or clinically implausible predictions, boosting both sensitivity and specificity simultaneously.
Unique Selling Points
- Clinical Impact through Explainability &
Regulatory Readiness - Patented Neuro-Symbolic Architecture for Diagnosis
- Economic Value Powered by World First Tele Radiologist
- Wider Coverage and full-blown diagnosis solution by First Oncology Large Model
- Scalability & Accessibility through Globally First structured platform, provide Patients and Hospitals in Tier 2/ tier 3 cities a secured video consultation between oncologists, radiologists
Scientific & Technological Edge
- Hybrid AI: Fusion of Hybrid AI with Deep Tech
- Explainable AI :
- Validated Innovation:
- Wider Research –
- Proven Outcomes:
See it in Action
NeuraXion Labs, the first product derived from our platform, is a clinical decision support tool that enables automated lung cancer screening.
Validated on +2,000 real cases from LIDC & Israeli hospitals databases and in the Assuta clinical study.
TumorXpert — fast, explainable AI for multimodal brain-tumor detection, molecular prediction, and intraoperative decision support.
TumorXpert offers a suite of powerful features designed to enhance diagnostic accuracy and efficiency.
Transformer and foundation-model architectures.
Transformers and large visual models are being applied to multi-sequence MRI and to combine modalities (histology, imaging, clinical) for better classification, segmentation, and prognostics
Radiogenomics — predicting molecular markers from imaging
Deep learning + radiomics pipelines can predict IDH/TERT/other mutation status and correlate imaging features with genomics, potentially reducing need for invasive testing and enabling precision therapy planning
Enabling Timely Intervention in Stroke Care
Receive diagnostic reports within minutes, allowing for prompt intervention and improved patient care.
Multi-Organ Cancer Coverage
India's first AI Oncology Foundation Model — adaptable for all major cancer types
Brain cancer
Ovarian cancer
Colon cancer
Breast cancer
Prostate cancer
Lungs cancer
What TumorXpert does (value)
Discover our latest innovations, achievements, and media highlights.
Accurate MRI segmentation & volumetrics
(multi-sequence transformer backbone) → reduces planning time, improves radiotherapy targeting.
Radiogenomic predictions
(IDH/TERT/grade) from MRI → faster stratification, fewer invasive tests.
Intraoperative tissue detection
(optical histology + fast inference) → reduce residual tumour, improve resection completeness.
Longitudinal monitoring dashboard
with growth curves, automatic relapse flags, and structured reports for MDs.
Target Market (B2B and D2P)
Direct To Patients
First structured D2P platform, provide Patients secured video consultation between oncologists, radiologists, Pathologist powered by TumorXpert. It create impact in democratizes expert opinion for complex tumor cases across geographies
Hospitals & Hospital Networks (Govt, Public, Private)
- Largest revenue segment driven by high imaging volumes and oncology programs
- Remote and tele-radiology services powered by AI for faster and high-quality reporting
- Improves radiologist productivity through intelligent case prioritization
- Enables secure video consultations for expert opinions in Tier 2 and Tier 3 cities
Diagnostic Centers & Cancer Institutes
- Supports MRI/CT centers, PET-CT facilities, and oncology hospitals
- Faster report turnaround with reduced operational cost
Insurance and OEM Providers
- Automates claims and reporting for high-value oncology treatments
- Integrated with Philips, GE, Siemens, and Canon
